Why Slow Dose Titration Prevents GLP-1 Overdose Risk Pharmaceutical guidelines recommend starting semaglutide at 0.25 mg weekly, increasing by 0.25 mg every four weeks until reaching a therapeutic dosetypically 1.02.4 mg weekly
Am J Physiol Endocrinol Metab 303: E253-264, 2012
D.FinemanM
As your appetite will be smaller, your calorie intake will naturally be less too
The platform's published materials describe a range of possible side effects patients may experience: Commonly reported mild effects include nausea, constipation, bloating, burping, mild headache, and fatigue effects that the patient protocols describe as typically improving as the body adjusts to the medication
Have significant medical complexity or multiple comorbidities: If you have multiple chronic conditions, take several medications, or have had complications with weight loss attempts in the past, you may benefit from the closer monitoring and integrated care available through a traditional medical practice rather than a telehealth-only platform